About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Arizona | 379 Studies

Clinical Trials Prostate CancerArizona

Prostate Cancer Clinical Trials in Arizona

Find 379 clinical trials for prostate cancer near Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 379 trials

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

CompletedPositioning and Tracking the Prostate During External Beam RadiationThe purpose of this study is to evaluate a non-ionizing electromagnetic method to align the prostate treatment site for radiation therapy and to monitor its position throughout…NCT00123838·Scottsdale, Arizona and 4 others

TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerThe purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no…NCT00089856·Alabaster, Alabama and 125 others

CompletedS9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy and hormone therapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004001·Scottsdale, Arizona and 15 others

TerminatedPhase II, Dose Finding Study of GTx-758The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.NCT01393119·Glendale, Arizona and 20 others

TerminatedEPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCThis is a Phase 1/2 study of EPI-7386 orally administered in combination with enzalutamide in subjects with mCRPC.NCT05075577·Tucson, Arizona and 23 others

Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

CompletedA Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerThis is a Phase 3 randomized, double blind, placebo controlled study of tasquinimod in asymptomatic to mildly symptomatic patients with metastatic CRPC to confirm the effect of…NCT01234311·Tucson, Arizona and 203 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC).NCT06925737·Phoenix, Arizona and 302 others

CompletedDose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPCThe combination treatment of protein kinase B (AKT) inhibitor, afuresertib, with androgen synthesis enzyme inhibitor, LAE001, may provide an effective treatment for metastatic…NCT04060394·Tucson, Arizona and 16 others

CompletedDarolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerThe purpose of the study is to assess the efficacy and safety of BAY1841788 (darolutamide (ODM-201)) in combination with standard androgen deprivation therapy (ADT) and docetaxel…NCT02799602·Chandler, Arizona and 321 others

CompletedMifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsThis is a study to assess the safety of the combination of mifepristone and eribulin in patients with metastatic or locally advanced unresectable breast or other specified solid…NCT02014337·Tucson, Arizona and 10 others

CompletedSelenium in Treating Patients With Prostate CancerRATIONALE: Selenium may prevent or slow the growth of prostate cancer.NCT00752739·Tucson, Arizona

CompletedNanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsThis pilot trial studies how well nanoparticle albumin-bound rapamycin works in treating patients with cancer that as has spread to other places in the body and usually cannot be…NCT02646319·Scottsdale, Arizona and 1 other

CompletedA Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesThis is a Phase 1, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity of…NCT03629756·Scottsdale, Arizona and 14 others

CompletedObservational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.NCT02380274·Homewood, Alabama and 147 others

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

CompletedCASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneThis is a phase II clinical trial in patients with metastatic castration sensitive prostate cancer.NCT03934840·Phoenix, Arizona and 7 others

PreviousPage 6 of 19Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma